Head-to-head comparison of pandemic influenza vaccines
- PMID: 21168368
- DOI: 10.1016/S1473-3099(10)70298-X
Head-to-head comparison of pandemic influenza vaccines
Comment on
-
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial.Lancet Infect Dis. 2011 Feb;11(2):91-101. doi: 10.1016/S1473-3099(10)70296-6. Epub 2010 Dec 16. Lancet Infect Dis. 2011. PMID: 21168369 Clinical Trial.
Similar articles
-
Immunogenicity and safety of pandemic H1N1 2009 vaccine among adults in field use, India.Vaccine. 2012 Mar 9;30(12):2043-4. doi: 10.1016/j.vaccine.2011.10.008. Epub 2011 Oct 14. Vaccine. 2012. PMID: 22001279 No abstract available.
-
Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.Jpn J Infect Dis. 2011;64(3):190-4. Jpn J Infect Dis. 2011. PMID: 21617301
-
[Pandemic vaccines].Arch Pediatr. 2010 Jun;17(6):906-7. doi: 10.1016/S0929-693X(10)70172-X. Arch Pediatr. 2010. PMID: 20654954 French. No abstract available.
-
Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine.Expert Rev Vaccines. 2010 Dec;9(12):1385-98. doi: 10.1586/erv.10.141. Expert Rev Vaccines. 2010. PMID: 21105775 Review.
-
Safety of influenza vaccines in pregnant women.Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S33-7. doi: 10.1016/j.ajog.2012.06.072. Epub 2012 Jul 9. Am J Obstet Gynecol. 2012. PMID: 22920057 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical